Particle.news
Download on the App Store

Integer Holdings Sued in SDNY Over EP Sales Disclosures After Guidance Cut

Plaintiffs cite October disclosures cutting 2025 guidance alongside warnings of slower adoption for new EP products.

Overview

  • The case, West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, No. 25-cv-10251, was filed in the Southern District of New York.
  • Complaints allege the company overstated its position in the electrophysiology market and portrayed EP devices as a durable growth driver despite deteriorating sales for two products.
  • On October 23, 2025, Integer lowered full-year 2025 sales guidance to $1.840–$1.854 billion and outlined 2026 net sales growth of -2% to 2% with organic growth of 0% to 4%, after which shares fell more than 32%.
  • Executives told investors that market adoption of several new products was slower than forecast and that three new products, including two EP devices, were expected to decline in 2026, with Cardio & Vascular sales decelerating.
  • Saxena White filed the suit, and Bronstein, Robbins Geller, and Rosen Law are soliciting investors to seek lead-plaintiff status by February 9, 2026.